Alan M Hoberman insider trades

Open-market stock purchases and sales by Alan M Hoberman, Director at Bioxytran, Inc, from SEC Form 4 filings since Mar 10, 2015.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -95%.

Recent trades

DateStockTradeValue
Nov 18, 2025BIXT Bioxytran, IncBought$126K
Nov 14, 2025BIXT Bioxytran, IncBought (not open market)$13.5K

Companies traded

  • BIXT Bioxytran, Inc: 1 buy, last Nov 18, 2025
  • BTHE Boston Therapeutics, Inc: 1 buy, last Mar 10, 2015

Get free alerts when Alan M Hoberman files a new trade →